MedPath

Evaluation of some chemical agents and phytocompounds on the cardiovascular system

Conditions
I10-I15
J84.1
Hypertensive diseases
Other interstitial pulmonary diseases with fibrosis
Registration Number
DRKS00011035
Lead Sponsor
niversity of Medicine and Pharmacy
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Male
Target Recruitment
187
Inclusion Criteria

Employees at the worksite with documented exposure to coal and crystalline silica, the total time of work at the worksites with documented exposure at least 10 years, and no current exposure to other chemical or physical factors

Exclusion Criteria

Patients with a pre-bronchodilator FEV1% predicted below 40% as well as a FEV1/FVC ratio below 45%

Study & Design

Study Type
observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The main aims of this study is to find the incidence of cardiovascular diseases in a group with patients exposed to coal and crystalline silica, and to correlate the risk of cardiovascular diseases with different factors and with the consumption of phytocompounds.
Secondary Outcome Measures
NameTimeMethod
There are many phytocompound that are very important to an alternative treatment of cardiovascular diseases. Extracts of ginger and hot chilli pepper have been chosen by our team to be encapsulated inside a polyurethane carrier and the products were evaluated by physical and chemical procedures, in vivo and in vitro tests.
© Copyright 2025. All Rights Reserved by MedPath